Aclaris Therapeutics Inc. (ACRS)
Aclaris Therapeutics Max Pain By Strike
ACRS trades at $1.93, 3.5% below the near-term max pain of $2 expiring Sep 19, 2025 (20 days). Price stability likely with balanced options positioning at this level. Max pain is falling across expirations ($1-$7), signaling increased put positioning or downside protection. Key magnetic zone at 1 where 3 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.
Aclaris Therapeutics Max Pain By Expiry
Max pain for ACRS shows a downward trend from 7 to 1, indicating bearish sentiment or hedging activity. The 257% spread signals divergent expectations across timeframes. Levels distributed around 1.93. Strong magnetic level at 1 (3 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 2 | 0.07 (3.63%) |
| Oct 17, 2025 | 1 | -0.93 (-48.19%) |
| Nov 21, 2025 | 2 | 0.07 (3.63%) |
| Dec 19, 2025 | 1 | -0.93 (-48.19%) |
| Jan 16, 2026 | 7 | 5.07 (262.69%) |
| Feb 20, 2026 | 1 | -0.93 (-48.19%) |